Linden Capital Partners completes acquisition of Alcresta Therapeutics, Inc. to bolster its healthcare industry portfolio
Mar 12, 2024•almost 2 years ago
Acquiring Company
Linden Capital Partners
Acquired Company
Alcresta Therapeutics
Description
Linden Capital Partners, a Chicago-based private equity firm specializing in the healthcare industry, has successfully acquired Alcresta Therapeutics, Inc. from Athyrium Capital, Bessemer Venture Partners, Frazier Healthcare Partners, and HealthQuest Capital. This strategic acquisition will further strengthen Linden's position in the healthcare industry and support the growth and commercialization of novel enzyme-based products for patients with gastrointestinal disorders and rare diseases.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed